Peptides containing SARS-CoV-2 spike-protein residues are antagonists of α7 and α9α10 nAChRs and modulate interleukin-1β release from human monocytic THP-1 cells
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2026.113391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Arik J Hone und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, University of Utah, Salt Lake City, Utah, USA; MIRECC, George E. Wahlen Veterans Affairs Medical Center, Salt Lake Cit…. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Interleukin-1beta, SARS-CoV-2, Receptors, Nicotinic. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Immune system dysregulation during COVID-19 illness remains an area of intense investigation. Excessive release of proinflammatory cytokines and multi-organ injury suggest aberrant control of the immune system. Given the established role of nicotinic acetylcholine receptors (nAChRs) in modulating inflammatory responses, we explored the possibility that the SARS-CoV-2 spike-protein may directly perturb this regulatory pathway. The spike protein contains a furin cleavage-site with sequence similarities to α-neurotoxins known to antagonize α7, α9, and α10 nAChR subtypes. To test whether this region of the spike protein can influence nAChR function, we synthesized short peptides corresponding to putative nAChR-interacting domains from several SARS-CoV-2 variants. Electrophysiological recordings from Xenopus laevis oocytes expressing human nAChRs revealed potent, virus-variant dependent inhibition of nAChR activity. In human monocytic THP-1 cells, these peptides reversed acetylcholine-mediated suppression of interleukin-1β release. Our findings identify a potential molecular mechanism by which SARS-CoV-2 may directly suppress nAChR signaling on immune cells thereby amplifying inflammatory cytokine release. This work supports the broader concept that structural motifs present in the SARS-CoV-2 spike-protein can disrupt cholinergic anti-inflammatory pathways and elucidates a mechanism that may contribute to the pathophysiology and immune system dysregulation that can occur in severe COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, University of Utah, Salt Lake City, Utah, USA; MIRECC, George E. Wahlen Veterans Affairs Medical Center, Salt Lake City, Utah, USA. Electronic address: uuneurotox@yahoo.com.
- Laboratory of Experimental Surgery, Department of General and Thoracic Surgery, German Center for Lung Research (DZL), Cardiopulmonary Institute (CPI), Justus-Liebig University Giessen, Giessen, Germany; Department of N…
- School of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.
- Laboratory of Experimental Surgery, Department of General and Thoracic Surgery, German Center for Lung Research (DZL), Cardiopulmonary Institute (CPI), Justus-Liebig University Giessen, Giessen, Germany.
- School of Biological Sciences, University of Utah, Salt Lake City, Utah, USA; Department of Psychiatry, University of Utah, Salt Lake City, Utah, USA; George E. Wahlen Veterans Affairs Medical Center, Salt Lake City, Ut…
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- Foundation for the National Institutes of Health
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Hone, A. J., Richter, K., Riaz, Z., Wakkuri, J., Tekarli, B., Gajewiak, J., Grau, V., & McIntosh, J. M. (2026). Peptides containing SARS-CoV-2 spike-protein residues are antagonists of α7 and α9α10 nAChRs and modulate interleukin-1β release from human monocytic THP-1 cells. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113391
Vancouver
Hone AJ, Richter K, Riaz Z, Wakkuri J, Tekarli B, Gajewiak J, et al. Peptides containing SARS-CoV-2 spike-protein residues are antagonists of α7 and α9α10 nAChRs and modulate interleukin-1β release from human monocytic THP-1 cells. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113391
BibTeX
@article{Hone2026,
author = {Hone, Arik J and Richter, Katrin and Riaz, Zoha and Wakkuri, Joseph and Tekarli, Bassel and Gajewiak, Joanna and Grau, Veronika and McIntosh, J Michael},
title = {Peptides containing SARS-CoV-2 spike-protein residues are antagonists of α7 and α9α10 nAChRs and modulate interleukin-1β release from human monocytic THP-1 cells},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.113391}
}
EUVIMED